Titre:
  • HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer.
Auteur:Azambuja, Evandro; Durbecq, Virginie; Rosa, Daniela D; Colozza, Mariantonietta; Larsimont, Denis; Piccart-Gebhart, Martine; Cardoso, Fatima
Informations sur la publication:Annals of oncology, 19, 2, page (223-232)
Statut de publication:Publié, 2008-02
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
ECD
HER-2 overexpression
Taxane resistance
Trastuzumab
MeSH keywords:Antibodies, Monoclonal -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Breast Neoplasms -- mortality
Breast Neoplasms -- surgery
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Mastectomy -- methods
Neoplasm Staging
Paclitaxel -- administration & dosage
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic
Receptor, erbB-2 -- genetics
Receptor, erbB-2 -- metabolism
Risk Assessment
Sensitivity and Specificity
Survival Analysis
Taxoids -- administration & dosage
Treatment Outcome
Tumor Markers, Biological -- analysis
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Review
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdm352
info:pii/mdm352
info:scp/38849127396
info:pmid/17872901